close

Fundraisings and IPOs

1 2 3 61
Number of results: 1209
Date Company Amount Funding type Investors Therapeutic area Type of Information
2017-05-08 Argen-X (Belgium - The Netherlands) private placement Private placement
2017-05-05 Amag Pharmaceuticals (USA - MA) private placement Private placement
2017-05-05 Achaogen (USA - CA) up to $20.5 million grant Bill & Melinda Gates Foundation (USA) Infectious diseases Grant
2017-05-04 Vivet Therapeutics (France) €37.5 million series A financing round Novartis Venture Fund (Switzerland) Columbus Venture Partners (Spain) Roche Venture Fund (Switzerland), HealthCap (Sweden) Kurma Partners (France) Ysios Capital (Spain) Rare diseases - Metabolic diseases Series A financing round
2017-05-02 Noxxon Pharma (Germany) € 11 million capital increase Cancer - Oncology Capital increase
2017-04-26 RegenXBio (USA - MD) $87.2 million private placement Rare diseases - Genetic diseases Private placement
2017-04-24 Oryzon Genomics (Spain) $300,000 grant Alzheimer’s Drug Discovery Foundation (ADDF) (USA - NY) Neurodegenerative diseases Grant
2017-04-21 Galapagos (Belgium) €363.9 million capital increase Capital increase
2017-04-17 Arena Pharmaceuticals (USA - CA) $79.4 million private placement Private placement
2017-04-13 Delmar Pharmaceuticals (USA - CA) $ 9 million private placement Cancer - Oncology Restructuring
2017-04-12 Polyphor (Switzerland) CHF 40 million (€ 37.43 million) private placement Varuma (Switzerland) Ingro Finanz (Switzerland) Infectious diseases Private placement
2017-04-04 Novosanis (Belgium) € 200 000 grant Interreg CrossCare (Belgium) Infectious diseases - Diagnostic Grant
2017-04-04 Repositive (UK) £2.5 million (€ 2.92 million) series A financing round Ananda Social Venture Fund (Germany) Force Over Mass Capital (UK) Amadeus Capital Partners (UK) Jonathan Milner Technology - Services Fundraising
2017-03-31 Osmia Pharmaceuticals (Sweden) SEK 42 million (€ 4.4 million) private placement Cancer - Oncology - Veterinary medicine Private placement
2017-03-31 Aveo Pharmaceuticals (USA - MA) $15.0 Million private placement Private placement
2017-03-30 Cidara Therapeutics (USA - CA) $6.9 million grant CARB-X (Combating Antibiotic Resistant Bacteria Accelerator) (USA) Infectious diseases Grant
2017-03-30 Tango Therapeutics (USA - MA) $55 million series A financing round Third Rock Ventures (USA - MA) Cancer - Oncology Fundraising
2017-03-30 Forge Therapeutics (USA - CA) $8.8 million grant CARB-X (Combating Antibiotic Resistant Bacteria Accelerator) (USA) Grant
2017-03-28 Nosopharm (France) €2.4 million financing round Auriga Partners (France) Kreaxi (France) Alto Invest (France) Infectious diseases Capital increase
2017-03-27 Adaptimmune (UK) $61.8 million IPO Cancer - Oncology Capital increase